Despite the emerging data on a pathogenic role of ACPA in RA (2–11, 55, 56), there is still limited knowledge concerning how the detailed specificities of different ACPA relate to functionality or to targeting of different effector cells. The gene discussed is PRTN3; the disease is rheumatoid arthritis.